These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28618875)

  • 41. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status.
    de Miguel-Díez J; Carrasco-Garrido P; Rejas-Gutierrez J; Martín-Centeno A; Gobartt-Vázquez E; Hernandez-Barrera V; Gil de MA; Jimenez-Garcia R
    Lung; 2011 Jun; 189(3):199-206. PubMed ID: 21499887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study.
    Di Martino M; Agabiti N; Bauleo L; Kirchmayer U; Cascini S; Pistelli R; Colamesta V; Patorno E; Pinnarelli L; Fusco D; Perucci CA; Davoli M;
    COPD; 2014 Aug; 11(4):414-23. PubMed ID: 24090036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initiation of triple therapy maintenance treatment among patients with COPD in the US.
    Simeone JC; Luthra R; Kaila S; Pan X; Bhagnani TD; Liu J; Wilcox TK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():73-83. PubMed ID: 28053518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD.
    Cazzola M; Molimard M
    Pulm Pharmacol Ther; 2010 Aug; 23(4):257-67. PubMed ID: 20381630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β
    Czira A; Banks V; Requena G; Wood R; Tritton T; Wild R; Compton C; Duarte M; Ismaila AS
    BMJ Open Respir Res; 2022 Sep; 9(1):. PubMed ID: 36171051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of newly diagnosed COPD patients treated with triple inhaled therapy by general practitioners: a real world Italian study.
    Di Marco F; Santus P; Terraneo S; Peruzzi E; Muscianisi E; Ripellino C; Pegoraro V
    NPJ Prim Care Respir Med; 2017 Sep; 27(1):51. PubMed ID: 28883469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What is the role of triple inhaled therapy in COPD?
    Petite SE
    JAAPA; 2019 Oct; 32(10):44-45. PubMed ID: 31567741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using Big Data to Assess Prescribing Patterns in Greece: The Case of Chronic Obstructive Pulmonary Disease.
    Souliotis K; Kani C; Papageorgiou M; Lionis D; Gourgoulianis K
    PLoS One; 2016; 11(5):e0154960. PubMed ID: 27191724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study.
    Amegadzie JE; Gamble JM; Farrell J; Gao Z
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2355-2366. PubMed ID: 33061353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
    Wang MT; Lai JH; Huang YL; Liou JT; Cheng SH; Lin CW; Pan HY; Hsu YJ; Tsai CL
    Chest; 2021 Oct; 160(4):1255-1270. PubMed ID: 34023320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication Discontinuation in Adults With COPD Discharged From the Hospital: A Population-Based Cohort Study.
    Gershon AS; McGihon RE; Thiruchelvam D; To T; Wu R; Bell CM; Aaron SD;
    Chest; 2021 Mar; 159(3):975-984. PubMed ID: 33011204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.